Document Detail

Results and outcomes after endoscopic treatment of upper urinary tract carcinoma: the Austrian experience.
MedLine Citation:
PMID:  23014836     Owner:  NLM     Status:  Publisher    
INTRODUCTION: Through evolution in technology, endoscopic treatment has gained popularity for the treatment of upper tract urothelial carcinoma (ENDO-UTUC). METHODS: A total of 20 patients with ENDO-UTUC were compared to 178 treated by radical nephroureterectomy (RNU) for a pTa-1 UTUC, and a systematic review was performed. RESULTS: Mean age for ENDO-UTUC was 71.9 ± 16.0 years, and tumor features were favorable (90 % papillary, 14 low grade, 11 pTa). All ENDO-UTUC were performed ureteroscopically. Mean follow-up was 20.4 ± 30 months. The 5-year overall survival (OS) rate was 45 %. Local (LR) and bladder recurrence (BR) was 25 and 15 %. Time to definitive treatment was longer, ASA higher, LR rates higher, OS lower for ENDO-UTUC (all p < 0.001), but no difference was recorded for BR (p = 0.056) and cancer-specific survival (CSS) (p = 0.364). Postoperative kidney function (KF) was better in the ENDO-UTUC (p = 0.048), though preoperative KF showed no difference. The maximal level of evidence was 3b, patients were highly selected, numbers of patients were low, and ASA scores high. OS was rather low and CSS high. LR rate was high (61 %) and BR rate moderate (39 %) for ureteroscopic and 36 and 28 %, respectively, for percutaneous approach. CONCLUSIONS: LR for ENDO-UTUC is high. In high-grade UTUC, oncological outcome is worse. RNU is associated with a significant loss of KF, but LR is rare. ENDO-UTUC is reserved for selected cases if elective. In imperative cases, it has to be balanced between KF, morbidity of the procedure, risk of operation and tumor control. ENDO-UTUC is not necessarily underused in Austria, because of lack in evidence, but 41 % of all RNU were performed in pTa/pTis/pT1 lesions.
Harun Fajkovic; Tobias Klatte; Udo Nagele; Michael Dunzinger; Richard Zigeuner; Wilhelm Hübner; Mesut Remzi
Related Documents :
23142556 - The clinical predictive factors for subsequent distant metastasis in patients with loco...
24617316 - Is there any association between where patients spend the end of life and survival afte...
24376936 - Tracheal cancer: role of radiation therapy.
8244906 - Prognostic factors in childhood acute lymphoblastic leukemia.
19306816 - Radical resection of biliary tract cancers and the role of extended lymphadenectomy.
23494836 - Sorafenib in patients with refractory or recurrent multiple myeloma.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-27
Journal Detail:
Title:  World journal of urology     Volume:  -     ISSN:  1433-8726     ISO Abbreviation:  World J Urol     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-9-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8307716     Medline TA:  World J Urol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Urology, Landesklinikum St. Poelten, St. Poelten, Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Total Hip Replacement Versus Open Reduction and Internal Fixation of Displaced Femoral Neck Fracture...
Next Document:  Functions of Transmembrane Domain 3 of Human Melanocortin-4 Receptor.